Reaction Details |
| Report a problem with these data |
Target | Protein kinase C beta type |
---|
Ligand | BDBM286345 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Protein Kinase C beta 2 Assay |
---|
Ki | 0.912±n/a nM |
---|
Citation | Li, H; Nukui, S; Scales, SA; Teng, M; Yin, C Substituted n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as protein kinase C inhibitors US Patent US11220518 Publication Date 1/11/2022 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Protein kinase C beta type |
---|
Name: | Protein kinase C beta type |
Synonyms: | KPCB_HUMAN | PKC alpha and beta-2 | PKC beta | PKC beta isoform 2 | PKCB | PRKCB | PRKCB1 | Protein Kinase C, beta II | Protein kinase C beta type | Protein kinase C beta type II (PRKCB2) |
Type: | Enzyme |
Mol. Mass.: | 76873.67 |
Organism: | Homo sapiens (Human) |
Description: | The recombinant human PKC enzymes were
produced using a baculovirus expression system in SF9 cells
|
Residue: | 671 |
Sequence: | MADPAAGPPPSEGEESTVRFARKGALRQKNVHEVKNHKFTARFFKQPTFCSHCTDFIWGF
GKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPASDDPRSKHKFKIHTYSSPTFCDHCGS
LLYGLIHQGMKCDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDRDVLIVLVRDA
KNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQLKESDKDRRL
SVEIWDWDLTSRNDFMGSLSFGISELQKASVDGWFKLLSQEEGEYFNVPVPPEGSEANEE
LRQKFERAKISQGTKVPEEKTTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSE
RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM
EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI
KIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP
FEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF
RYIDWEKLERKEIQPPYKPKARDKRDTSNFDKEFTRQPVELTPTDKLFIMNLDQNEFAGF
SYTNPEFVINV
|
|
|
BDBM286345 |
---|
n/a |
---|
Name | BDBM286345 |
Synonyms: | US11220518, Ex. No. K3 | US11780853, Example K3 | US9518060, Example K3 |
Type | Small organic molecule |
Emp. Form. | C22H33FN8O2 |
Mol. Mass. | 460.5482 |
SMILES | CCOc1ncc(F)c(Nc2n[nH]c3c2CN(C(=O)N2CC(C)(C)N(C)C[C@@H]2C)C3(C)C)n1 |r| |
Structure |
|